JAM-C Expression as a Biomarker to Predict Outcome of Patients with Acute Myeloid Leukemia-Response

Cancer Res. 2018 Nov 1;78(21):6342-6343. doi: 10.1158/0008-5472.CAN-18-0834. Epub 2018 Oct 17.

Authors

Maria De Grandis¹, Stéphane J C Mancini¹, Norbert Vey^{1

2

3}, Michel Aurrand-Lions⁴

Affiliations

¹ Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France.
² Département de Biopathologie, Cytogénétique et Biologie Moléculaire, Institut Paoli-Calmettes, Aix Marseille Université, Marseille, France.
³ Département d'Hématologie, Institut Paoli-Calmettes, Aix Marseille Université, Marseille, France.
⁴ Aix-Marseille Univ, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Marseille, France. michel.aurrand-lions@inserm.fr.

PMID: 30333117
DOI: 10.1158/0008-5472.CAN-18-0834

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Humans
Leukemia, Myeloid, Acute*
Prognosis
src-Family Kinases*

Substances

Biomarkers
src-Family Kinases